Current Appointments & Affiliations
Clinical Data Spec III
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
The DILI-Inpt Prognostic Score to Identify Hospitalized Idiosyncratic DILI Patients at Risk for Adverse Outcomes
Journal Article Clinical Gastroenterology and Hepatology · November 2025 Full text CiteInvestigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.
Journal Article Drug Saf · February 2025 BACKGROUND: The attribution of drug-induced liver injury (DILI) to specific herbal and dietary supplements (HDS) is confounded by inaccurate labels and undisclosed ingredients. The US Drug-Induced Liver Injury Network (DILIN) determines the attribution of ... Full text Link to item CiteTHE ROLE OF CHEMICAL ANALYSIS IN CAUSALITY ASSESSMENT OF HERBAL AND DIETARY SUPPLEMENT (HDS) INDUCED LIVER INJURY
Conference HEPATOLOGY · October 2021 Link to item CiteRecent Grants
Drug Induced Liver Injury Network Data Coordinating Center
ResearchClinical Data Specialist · Awarded by National Institutes of Health · 2003 - 2028A Phase 1b MAD Study of TT301/MW189
Clinical TrialClinical Data Specialist · Awarded by University of Kentucky · 2017 - 2019Coordinating Center for the Drug Induced Liver Injury Network (DILIN) - Competitive Renewal
Clinical TrialClinical Data Assistant, III · Awarded by National Institutes of Health · 2008 - 2018View All Grants